| Title: |
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial |
| Authors: |
Blauvelt, Andrew a, ∗; Draelos, Zoe D. b; Stein Gold, Linda c; Alonso-Llamazares, Javier d; Bhatia, Neal e; DuBois, Janet f; Forman, Seth B. g; Gooderham, Melinda h; Green, Lawrence i; Guenthner, Scott T. j, k; Hebert, Adelaide A. l; Lain, Edward m; Moore, Angela Y. n, o; Papp, Kim A. p, q; Zirwas, Matthew r, s, t; Kato, Saori u; Snyder, Scott u; Krupa, David u; Burnett, Patrick u; Berk, David R. u; Chu, David H. u |
| Source: |
In Journal of the American Academy of Dermatology May 2024 90(5):986-993 |
| Database: |
ScienceDirect |